Skip to main content

Susanna High

Equibles does not estimate personal net worth.

About Susanna High

Earlier roles on record: COO at Dyne Therapeutics, Inc. (DYN) until October 1, 2024. Dyne Therapeutics, Inc. reported in an 8-K filed September 3, 2024 that Susanna High resigned as Chief Operating Officer, effective October 1, 2024. The proxy statement of Dyne Therapeutics, Inc. reports total compensation of $2,045,442 for Susanna High in fiscal 2023, including a base salary of $497,888. Disclosed compensation is on record for 4 fiscal years.

“Dr. McNeill’s resignation is effective September 3, 2024, and Ms. High’s resignation is effective October 1, 2024.”
Dyne Therapeutics, Inc. Form 8-K, filed September 3, 2024 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Dyne Therapeutics, Inc. (DYN) $497,888 $2,045,442
2022 Dyne Therapeutics, Inc. (DYN) $467,500 $1,594,292
2021 Dyne Therapeutics, Inc. (DYN) $425,000 $1,690,621
2020 Dyne Therapeutics, Inc. (DYN) $167,788 $3,745,915

Recent activity